gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Experimental Hepatoma in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, CC; Chen, CY; Chen, SH; Cheng, TL; Chiu, YY; Jaw, TS; Kuo, YT; Lai, JJ; Liu, GC; Wang, YM | 1 |
Bouzin, C; Cron, GO; Feron, O; Fruytier, AC; Gallez, B; Jordan, B; Karroum, O; Magat, J; Neveu, MA | 1 |
Bücker, A; Fries, P; Lux, F; Massmann, A; Menger, MD; Morr, D; Müller, A; Schäfer, T; Schneider, G; Seidel, R; Tillement, O | 1 |
Abarca-Quinones, J; Annet, L; Dorvillius, M; Huwart, L; Michoux, N; Peeters, F; Van Beers, BE | 1 |
Chang, Y; Ha, S; Jung, JC; Kim, TJ; Lee, JJ; Oh, C; Park, JA; Yu, DY | 1 |
Baert, AL; Lodemann, KP; Marchal, G; Michiels, J; Ni, Y; Rummeny, E; Van Hecke, P; Yu, J; Zhang, X | 1 |
6 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Experimental Hepatoma
Article | Year |
---|---|
In vivo magnetic resonance imaging of mice liver tumors using a new gadolinium-based contrast agent.
Topics: Animals; Cell Line, Tumor; Contrast Media; Coordination Complexes; Glucuronates; Heterocyclic Compounds; Liver; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Optical Imaging; Organometallic Compounds | 2013 |
Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
Topics: Animals; Animals, Outbred Strains; Antineoplastic Agents, Phytogenic; Capillary Permeability; Contrast Media; Drug Monitoring; Endothelial Cells; Feasibility Studies; Hemodynamics; Heterocyclic Compounds; Hindlimb; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Mice; Molecular Weight; Neoplasm Transplantation; Organometallic Compounds; Stilbenes; Transplantation, Heterotopic; Tubulin Modulators; Tumor Burden | 2014 |
Evaluation of a Gadolinium-Based Nanoparticle (AGuIX) for Contrast-Enhanced MRI of the Liver in a Rat Model of Hepatic Colorectal Cancer Metastases at 9.4 Tesla.
Topics: Animals; Colorectal Neoplasms; Contrast Media; Female; Heterocyclic Compounds; Image Processing, Computer-Assisted; Liver; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Nanoparticles; Neoplasm Transplantation; Organometallic Compounds; Radiographic Image Enhancement; Rats; Rats, Inbred Strains; Reference Values; Siloxanes | 2015 |
Transvascular and interstitial transport in rat hepatocellular carcinomas: dynamic contrast-enhanced MRI assessment with low- and high-molecular weight agents.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Heterocyclic Compounds; Image Processing, Computer-Assisted; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Molecular Weight; Organometallic Compounds; Rats; Rats, Wistar; Statistics, Nonparametric | 2008 |
Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent.
Topics: Animals; Cell Line; Cell Survival; Chickens; Contrast Media; Genes, ras; Heterocyclic Compounds; Integrin alphaVbeta3; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Neoplasm Transplantation; Oligopeptides; Organometallic Compounds; Protein Binding | 2008 |
The uptake of manganese dipyridoxal-diphosphate by chemically induced hepatocellular carcinoma in rats. A correlation between contrast-media-enhanced magnetic resonance imaging, tumor differentiation, and vascularization.
Topics: Angiography; Animals; Contrast Media; Edetic Acid; Heterocyclic Compounds; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Microradiography; Organometallic Compounds; Pyridoxal Phosphate; Rats; Rats, Wistar | 1993 |